מיפג'ין

Kraj: Izrael

Język: hebrajski

Źródło: Ministry of Health

Składnik aktywny:

MIFEPRISTONE

Dostępny od:

A. LAPIDOT PHARMACEUTICALS, LTD

Kod ATC:

G03XB01

Forma farmaceutyczna:

טבליה

Skład:

MIFEPRISTONE 200 MG

Droga podania:

פומי

Typ recepty:

מרשם נדרש

Wyprodukowano przez:

EXELGYNE LABORATORIES, FRANCE

Grupa terapeutyczna:

MIFEPRISTONE

Dziedzina terapeutyczna:

MIFEPRISTONE

Wskazania:

Medical alternative to uterine suction for termination of intra-utrerine Pregnancy: - up to and no later than 49 days of amenorrhea (seven weeks) - in sequential use with a prostaglandin analogue misoprostol 400 mcg per os administered 36 to 48 hours after Mifegyne intake. Under these conditions the association of mifepristone and prostaglandins leads to a success rate of about 95 per cent of the cases. Preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reason (beyond the first trimester). Softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.

Data autoryzacji:

2014-07-31